Physician profile
Melissa Walco
NPI 1184967440
$1,055.64
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.81 · 2020: $160 · 2021: $322 · 2022: $442 · 2024: $32.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $32.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $32.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $377.16 | 2020-2022 | |
| Aspira Women'S Health INC | $111.50 | 2022 | |
| Organon LLC | $79.67 | 2021-2024 | |
| Avion Pharmaceuticals | $75.48 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $66.13 | 2019-2022 | |
| Channel Medsystems, INC. | $62.40 | 2022 | |
| Merck Sharp & Dohme LLC | $59.59 | 2019-2022 | |
| Exeltis, USA INC. | $43.13 | 2019-2022 | |
| Daiichi Sankyo INC. | $36.41 | 2019-2021 | |
| Agile Therapeutics, INC. | $35.72 | 2021-2022 | |
| Allergan, INC. | $24.77 | 2019 | |
| Millicent US INC | $19.91 | 2022 | |
| Avanos Medical | $16.73 | 2019 | |
| Evofem Biosciences, INC. | $12.60 | 2021 | |
| Olympus America INC. | $11.95 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $11.31 | 2020 | |
| Vertical Pharmaceuticals, LLC | $11.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Walco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.